nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipecuronium—CHRNA2—epilepsy syndrome	0.378	0.471	CbGaD
Pipecuronium—CHRM3—epilepsy syndrome	0.177	0.221	CbGaD
Pipecuronium—CHRM2—epilepsy syndrome	0.135	0.168	CbGaD
Pipecuronium—BCHE—epilepsy syndrome	0.113	0.14	CbGaD
Pipecuronium—CHRNA1—tongue—epilepsy syndrome	0.00417	0.156	CbGeAlD
Pipecuronium—Vecuronium—CHRNA2—epilepsy syndrome	0.00157	0.212	CrCbGaD
Pipecuronium—CHRNA2—forebrain—epilepsy syndrome	0.00147	0.055	CbGeAlD
Pipecuronium—Rocuronium—CHRNA2—epilepsy syndrome	0.0014	0.189	CrCbGaD
Pipecuronium—Pancuronium—CHRNA2—epilepsy syndrome	0.00134	0.18	CrCbGaD
Pipecuronium—CHRNA1—head—epilepsy syndrome	0.00101	0.038	CbGeAlD
Pipecuronium—CHRNB1—medulla oblongata—epilepsy syndrome	0.000987	0.037	CbGeAlD
Pipecuronium—Rocuronium—SLCO1A2—epilepsy syndrome	0.000931	0.125	CrCbGaD
Pipecuronium—CHRNB1—midbrain—epilepsy syndrome	0.000902	0.0338	CbGeAlD
Pipecuronium—CHRNB1—spinal cord—epilepsy syndrome	0.00088	0.033	CbGeAlD
Pipecuronium—CHRM2—forebrain—epilepsy syndrome	0.000875	0.0328	CbGeAlD
Pipecuronium—CHRNA2—head—epilepsy syndrome	0.00084	0.0315	CbGeAlD
Pipecuronium—CHRM2—telencephalon—epilepsy syndrome	0.000805	0.0302	CbGeAlD
Pipecuronium—CHRNA2—nervous system—epilepsy syndrome	0.000797	0.0299	CbGeAlD
Pipecuronium—CHRNB1—head—epilepsy syndrome	0.000782	0.0293	CbGeAlD
Pipecuronium—CHRNA2—central nervous system—epilepsy syndrome	0.000767	0.0288	CbGeAlD
Pipecuronium—CHRNA2—cerebellum—epilepsy syndrome	0.00075	0.0281	CbGeAlD
Pipecuronium—CHRNA1—brain—epilepsy syndrome	0.000734	0.0275	CbGeAlD
Pipecuronium—CHRM3—forebrain—epilepsy syndrome	0.000713	0.0267	CbGeAlD
Pipecuronium—CHRNB1—cerebellum—epilepsy syndrome	0.000698	0.0262	CbGeAlD
Pipecuronium—CHRM3—telencephalon—epilepsy syndrome	0.000656	0.0246	CbGeAlD
Pipecuronium—Pancuronium—CHRM3—epilepsy syndrome	0.000628	0.0845	CrCbGaD
Pipecuronium—CHRNA2—brain—epilepsy syndrome	0.000609	0.0228	CbGeAlD
Pipecuronium—BCHE—brainstem—epilepsy syndrome	0.000603	0.0226	CbGeAlD
Pipecuronium—BCHE—forebrain—epilepsy syndrome	0.000582	0.0218	CbGeAlD
Pipecuronium—CHRNB1—brain—epilepsy syndrome	0.000567	0.0213	CbGeAlD
Pipecuronium—BCHE—telencephalon—epilepsy syndrome	0.000535	0.0201	CbGeAlD
Pipecuronium—Rocuronium—CHRM2—epilepsy syndrome	0.000501	0.0674	CrCbGaD
Pipecuronium—CHRM2—head—epilepsy syndrome	0.000501	0.0188	CbGeAlD
Pipecuronium—Pancuronium—CHRM2—epilepsy syndrome	0.000478	0.0643	CrCbGaD
Pipecuronium—CHRM2—nervous system—epilepsy syndrome	0.000475	0.0178	CbGeAlD
Pipecuronium—CHRM2—central nervous system—epilepsy syndrome	0.000457	0.0172	CbGeAlD
Pipecuronium—BCHE—medulla oblongata—epilepsy syndrome	0.00042	0.0158	CbGeAlD
Pipecuronium—CHRM3—head—epilepsy syndrome	0.000408	0.0153	CbGeAlD
Pipecuronium—Pancuronium—BCHE—epilepsy syndrome	0.000399	0.0536	CrCbGaD
Pipecuronium—CHRM3—nervous system—epilepsy syndrome	0.000387	0.0145	CbGeAlD
Pipecuronium—BCHE—midbrain—epilepsy syndrome	0.000384	0.0144	CbGeAlD
Pipecuronium—BCHE—spinal cord—epilepsy syndrome	0.000375	0.0141	CbGeAlD
Pipecuronium—CHRM3—central nervous system—epilepsy syndrome	0.000373	0.014	CbGeAlD
Pipecuronium—CHRM2—brain—epilepsy syndrome	0.000363	0.0136	CbGeAlD
Pipecuronium—BCHE—head—epilepsy syndrome	0.000333	0.0125	CbGeAlD
Pipecuronium—BCHE—nervous system—epilepsy syndrome	0.000316	0.0118	CbGeAlD
Pipecuronium—BCHE—central nervous system—epilepsy syndrome	0.000304	0.0114	CbGeAlD
Pipecuronium—BCHE—cerebellum—epilepsy syndrome	0.000297	0.0111	CbGeAlD
Pipecuronium—CHRM3—brain—epilepsy syndrome	0.000296	0.0111	CbGeAlD
Pipecuronium—BCHE—brain—epilepsy syndrome	0.000241	0.00906	CbGeAlD
Pipecuronium—Vecuronium—ABCB1—epilepsy syndrome	0.000184	0.0247	CrCbGaD
Pipecuronium—CHRM2—GPCR downstream signaling—CNR1—epilepsy syndrome	1.04e-05	6.41e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—PLCB1—epilepsy syndrome	1.04e-05	6.39e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GRM8—epilepsy syndrome	1.04e-05	6.39e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PGF—epilepsy syndrome	1.04e-05	6.39e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—SST—epilepsy syndrome	1.03e-05	6.37e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—CCR2—epilepsy syndrome	1.03e-05	6.37e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PGF—epilepsy syndrome	1.03e-05	6.32e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GRM8—epilepsy syndrome	1.03e-05	6.32e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HTR7—epilepsy syndrome	1.03e-05	6.32e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—SST—epilepsy syndrome	1.02e-05	6.31e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—CCR2—epilepsy syndrome	1.02e-05	6.31e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HTR7—epilepsy syndrome	1.02e-05	6.26e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—POMC—epilepsy syndrome	1.02e-05	6.25e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—ADRA2A—epilepsy syndrome	1.01e-05	6.24e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—POMC—epilepsy syndrome	1.01e-05	6.19e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—ADRA2A—epilepsy syndrome	1e-05	6.18e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR ligand binding—CCL2—epilepsy syndrome	9.93e-06	6.12e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GNAO1—epilepsy syndrome	9.89e-06	6.09e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—OPRD1—epilepsy syndrome	9.89e-06	6.09e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR ligand binding—CCL2—epilepsy syndrome	9.83e-06	6.06e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	9.8e-06	6.04e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GNAO1—epilepsy syndrome	9.79e-06	6.03e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—OPRD1—epilepsy syndrome	9.79e-06	6.03e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—AKT3—epilepsy syndrome	9.77e-06	6.02e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—CYP2D6—epilepsy syndrome	9.77e-06	6.02e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—CXCL12—epilepsy syndrome	9.72e-06	5.99e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—BDKRB2—epilepsy syndrome	9.72e-06	5.99e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—AKT3—epilepsy syndrome	9.68e-06	5.96e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—BDKRB2—epilepsy syndrome	9.63e-06	5.93e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—CXCL12—epilepsy syndrome	9.63e-06	5.93e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—CNR1—epilepsy syndrome	9.55e-06	5.88e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—PLCB1—epilepsy syndrome	9.51e-06	5.86e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CCR7—epilepsy syndrome	9.48e-06	5.84e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GRM1—epilepsy syndrome	9.48e-06	5.84e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CHRM1—epilepsy syndrome	9.48e-06	5.84e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PDYN—epilepsy syndrome	9.48e-06	5.84e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—CNR1—epilepsy syndrome	9.45e-06	5.82e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—PLCB1—epilepsy syndrome	9.42e-06	5.8e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GRM1—epilepsy syndrome	9.39e-06	5.78e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CCR7—epilepsy syndrome	9.39e-06	5.78e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PDYN—epilepsy syndrome	9.39e-06	5.78e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CHRM1—epilepsy syndrome	9.39e-06	5.78e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HTR7—epilepsy syndrome	9.31e-06	5.74e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—ADRA2A—epilepsy syndrome	9.3e-06	5.73e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism of proteins—POMC—epilepsy syndrome	9.29e-06	5.72e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HTR7—epilepsy syndrome	9.22e-06	5.68e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism of proteins—CCL2—epilepsy syndrome	9.09e-06	5.6e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HBEGF—epilepsy syndrome	9.04e-06	5.57e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HBEGF—epilepsy syndrome	8.95e-06	5.52e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—CDC42—epilepsy syndrome	8.92e-06	5.49e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GFAP—epilepsy syndrome	8.91e-06	5.49e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GAL—epilepsy syndrome	8.91e-06	5.49e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—AKT3—epilepsy syndrome	8.87e-06	5.47e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—SLC2A1—epilepsy syndrome	8.83e-06	5.44e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—CDC42—epilepsy syndrome	8.83e-06	5.44e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GFAP—epilepsy syndrome	8.83e-06	5.44e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GAL—epilepsy syndrome	8.83e-06	5.44e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GRM5—epilepsy syndrome	8.81e-06	5.43e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CASP2—epilepsy syndrome	8.81e-06	5.43e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—AKT3—epilepsy syndrome	8.79e-06	5.41e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—PLCB1—epilepsy syndrome	8.74e-06	5.38e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GRM5—epilepsy syndrome	8.73e-06	5.38e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CASP2—epilepsy syndrome	8.73e-06	5.38e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CHRM3—epilepsy syndrome	8.73e-06	5.38e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—TH—epilepsy syndrome	8.71e-06	5.36e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—AVP—epilepsy syndrome	8.63e-06	5.32e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—ABCG2—epilepsy syndrome	8.59e-06	5.29e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.57e-06	5.28e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—AVP—epilepsy syndrome	8.55e-06	5.27e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CX3CR1—epilepsy syndrome	8.45e-06	5.21e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—CYP2C19—epilepsy syndrome	8.37e-06	5.16e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CX3CR1—epilepsy syndrome	8.37e-06	5.16e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—CYP11A1—epilepsy syndrome	8.32e-06	5.13e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	8.29e-06	5.11e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	8.29e-06	5.11e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	8.29e-06	5.11e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	8.21e-06	5.06e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	8.21e-06	5.06e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	8.1e-06	4.99e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	8.06e-06	4.97e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	8.02e-06	4.94e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	7.98e-06	4.92e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	7.84e-06	4.83e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	7.76e-06	4.78e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	7.73e-06	4.76e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	7.65e-06	4.72e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	7.61e-06	4.69e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	7.54e-06	4.64e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	7.51e-06	4.63e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	7.34e-06	4.52e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	7.27e-06	4.48e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—HMOX1—epilepsy syndrome	7.27e-06	4.48e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	7.19e-06	4.43e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	7.18e-06	4.42e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—CAT—epilepsy syndrome	7.17e-06	4.42e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	7.15e-06	4.41e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—BCHE—epilepsy syndrome	7.12e-06	4.39e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	7.12e-06	4.38e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	7.11e-06	4.38e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	7e-06	4.31e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	7e-06	4.31e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—ABCB1—epilepsy syndrome	6.97e-06	4.3e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	6.93e-06	4.27e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	6.93e-06	4.27e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	6.81e-06	4.2e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	6.79e-06	4.19e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	6.76e-06	4.16e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	6.76e-06	4.16e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	6.76e-06	4.16e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	6.76e-06	4.16e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	6.76e-06	4.16e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	6.75e-06	4.16e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—PLCB1—epilepsy syndrome	6.72e-06	4.14e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—TH—epilepsy syndrome	6.69e-06	4.12e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	6.69e-06	4.12e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	6.69e-06	4.12e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	6.69e-06	4.12e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	6.69e-06	4.12e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	6.69e-06	4.12e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	6.66e-06	4.11e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	6.6e-06	4.07e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	6.52e-06	4.02e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—GPX1—epilepsy syndrome	6.48e-06	3.99e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	6.46e-06	3.98e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.3e-06	3.88e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	6.28e-06	3.87e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	6.28e-06	3.87e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	6.24e-06	3.84e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	6.22e-06	3.83e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	6.22e-06	3.83e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	6.19e-06	3.81e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	6.13e-06	3.78e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	6.11e-06	3.76e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—SST—epilepsy syndrome	6.11e-06	3.76e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	6.11e-06	3.76e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	6.06e-06	3.73e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	6.05e-06	3.73e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	6.05e-06	3.73e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—SST—epilepsy syndrome	6.05e-06	3.73e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	6e-06	3.7e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	5.98e-06	3.68e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	5.95e-06	3.67e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	5.92e-06	3.65e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	5.9e-06	3.63e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	5.74e-06	3.54e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	5.74e-06	3.54e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	5.74e-06	3.53e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	5.72e-06	3.52e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	5.7e-06	3.51e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	5.69e-06	3.5e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	5.69e-06	3.5e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—AGT—epilepsy syndrome	5.69e-06	3.5e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	5.68e-06	3.5e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	5.66e-06	3.49e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	5.64e-06	3.47e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	5.64e-06	3.47e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	5.64e-06	3.47e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	5.62e-06	3.46e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—HMOX1—epilepsy syndrome	5.59e-06	3.44e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	5.58e-06	3.44e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	5.58e-06	3.44e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—APOE—epilepsy syndrome	5.57e-06	3.43e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	5.56e-06	3.43e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—CAT—epilepsy syndrome	5.51e-06	3.4e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	5.5e-06	3.39e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	5.45e-06	3.36e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—ABCB1—epilepsy syndrome	5.36e-06	3.3e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	5.34e-06	3.29e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	5.29e-06	3.26e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	5.24e-06	3.23e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	5.21e-06	3.21e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	5.19e-06	3.2e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	5.16e-06	3.18e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	5.12e-06	3.15e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	5.1e-06	3.14e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	5.07e-06	3.12e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	5.05e-06	3.11e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—GPX1—epilepsy syndrome	4.99e-06	3.07e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	4.84e-06	2.98e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	4.79e-06	2.95e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	4.79e-06	2.95e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—POMC—epilepsy syndrome	4.79e-06	2.95e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	4.78e-06	2.95e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	4.75e-06	2.93e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	4.74e-06	2.92e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	4.63e-06	2.85e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	4.59e-06	2.83e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	4.38e-06	2.7e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—AGT—epilepsy syndrome	4.37e-06	2.69e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—ALB—epilepsy syndrome	4.36e-06	2.69e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	4.34e-06	2.67e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—APOE—epilepsy syndrome	4.28e-06	2.64e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	4.26e-06	2.62e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	4.24e-06	2.61e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	4.24e-06	2.61e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	4.22e-06	2.6e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	4.2e-06	2.59e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	4.19e-06	2.58e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	4.09e-06	2.52e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	4.05e-06	2.5e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	4.05e-06	2.49e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	4.01e-06	2.47e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	3.94e-06	2.43e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	3.9e-06	2.4e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	3.85e-06	2.37e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—PTGS2—epilepsy syndrome	3.82e-06	2.35e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	3.82e-06	2.35e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—POMC—epilepsy syndrome	3.68e-06	2.27e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	3.66e-06	2.26e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	3.66e-06	2.25e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	3.62e-06	2.23e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	3.62e-06	2.23e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	3.58e-06	2.21e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	3.55e-06	2.19e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	3.51e-06	2.16e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	3.48e-06	2.14e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	3.38e-06	2.08e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	3.36e-06	2.07e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—ALB—epilepsy syndrome	3.36e-06	2.07e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	3.35e-06	2.06e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	3.33e-06	2.05e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	3.08e-06	1.9e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	3.05e-06	1.88e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	3.01e-06	1.85e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	2.98e-06	1.84e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—PTGS2—epilepsy syndrome	2.94e-06	1.81e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	2.72e-06	1.68e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	2.69e-06	1.66e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	2.53e-06	1.56e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	2.5e-06	1.54e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	2.48e-06	1.53e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	2.45e-06	1.51e-05	CbGpPWpGaD
Pipecuronium—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	2.3e-06	1.42e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	2.28e-06	1.4e-05	CbGpPWpGaD
Pipecuronium—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	2.28e-06	1.4e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	2.26e-06	1.39e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	2.21e-06	1.36e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	2.19e-06	1.35e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	2.15e-06	1.33e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	2.13e-06	1.31e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	2.09e-06	1.29e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	2.07e-06	1.27e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.98e-06	1.22e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.97e-06	1.21e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.93e-06	1.19e-05	CbGpPWpGaD
Pipecuronium—BCHE—Metabolism—AKT1—epilepsy syndrome	1.92e-06	1.18e-05	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.91e-06	1.18e-05	CbGpPWpGaD
Pipecuronium—CHRM3—Metabolism—AKT1—epilepsy syndrome	1.48e-06	9.09e-06	CbGpPWpGaD
Pipecuronium—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	1.23e-06	7.6e-06	CbGpPWpGaD
Pipecuronium—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	1.22e-06	7.53e-06	CbGpPWpGaD
